The long-term objective of the proposed research will be to gain an understanding of RNA structure and function with an emphasis on RNA catalyzed reactions. Diseases due to RNA splicing defects, such as certain forms of thalassemia, are due to mutations which affect accuracy in a reaction for which RNA may play an important catalytic role. The system that will be studied is derived from the self-splicing IVS encoded in the Tetrahymena macronuclear pre-rRNA gene. Altered forms of the IVS will be studied as to the effects on splicing and reverse splicing activity, stability, and a novel form of the IVS catalyzed RNA polymerase activity. All group I IVSs have the potential to form a conserved secondary structure (involving about 100 of the 413 nucleotides in the Tetrahymena IVS). It is hypothesized that this conserved structure forms the """"""""core"""""""" three dimensional structure which is the catalytic center of the IVS. Most studies involving mutagenesis have been directed at testing specific features of the core structure. Random mutagenesis has not been fully exploited in this system as a means of identifying critical sequences and structures. Random mutations, both single-base changes and linker insertions, will be made to examine the role of both core and non-core structures. Mutations in the core will, most likely, affect catalytic activity directly whereas mutations outside of the core may be expected to affect overall stability or flexibility of the IVS. The linker library will be used to generate linker scanner mutants and nested deletions of specific sequences and structures. Although each step in splicing appears to be reversible, the total reverse reaction, IVS integration, has not been demonstrated. The forward direction may be driven by circularization, which removes one of the products of splicing. An in vitro system which will detect reverse splicing will be developed using mutants which do not circularize. Results from these experiments would be of significance to the question of whether self-splicing RNA could act as mobile genetic elements. A variation of the nucleotidyl transferase reaction, catalyzed by a portion of the IVS, has been found in which a primer is elongated in the 5' to 3' direction by the successive addition of mononucleotides. The potential for this reaction to be template directed will be studied.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29GM040689-04
Application #
3467276
Study Section
Molecular Biology Study Section (MBY)
Project Start
1988-07-01
Project End
1993-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Puttaraju, M; Been, M D (1996) Circularizing ribozymes and decoy-competitors by autocatalytic splicing in vitro and in vivo. SAAS Bull Biochem Biotechnol 9:77-82
Puttaraju, M; Been, M D (1996) Circular ribozymes generated in Escherichia coli using group I self-splicing permuted intron-exon sequences. J Biol Chem 271:26081-7
Rosenstein, S P; Been, M D (1996) Hepatitis delta virus ribozymes fold to generate a solvent-inaccessible core with essential nucleotides near the cleavage site phosphate. Biochemistry 35:11403-13
Puttaraju, M; Been, M D (1995) Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing. Nucleic Acids Symp Ser :49-51
Puttaraju, M; Beebe, J A; Niranjanakumari, S et al. (1995) Generation and characterization of circular Bacillus subtilis RNase P RNA;activation by RNase P protein. Nucleic Acids Symp Ser :92-4
Puttaraju, M; Been, M D (1995) Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing. Nucleic Acids Symp Ser :152-5
Been, M D (1994) Cis- and trans-acting ribozymes from a human pathogen, hepatitis delta virus. Trends Biochem Sci 19:251-6
Puttaraju, M; Perrotta, A T; Been, M D (1993) A circular trans-acting hepatitis delta virus ribozyme. Nucleic Acids Res 21:4253-8
Perrotta, A T; Been, M D (1993) Assessment of disparate structural features in three models of the hepatitis delta virus ribozyme. Nucleic Acids Res 21:3959-65
Been, M D; Perrotta, A T; Rosenstein, S P (1992) Secondary structure of the self-cleaving RNA of hepatitis delta virus: applications to catalytic RNA design. Biochemistry 31:11843-52

Showing the most recent 10 out of 17 publications